6 quiz questions available for this topicTake Quiz

Antenatal care - uncomplicated pregnancy

SNOMED: 169574001799 wordsUpdated 03/03/2026
💡

Exam Tips

  • Know the UK routine contact pattern: nulliparous 10 appointments, parous 7, plus scans at 11+2 to 14+1 and 18+0 to 20+6 weeks.
  • In OSCE stations, always include safeguarding and mental health questions, and ensure a private consultation opportunity.
  • State clear escalation triggers: hypertension/proteinuria, vaginal bleeding, reduced fetal movements, severe headache/visual symptoms, abnormal scan findings, or social risk concerns.
  • Memorise key supplement doses: folic acid 400 micrograms daily (5 mg high-risk) and vitamin D 10 micrograms/400 IU daily.
  • Medication safety is a scoring domain: perform a full medicines reconciliation including OTC/herbal products and check teratogenic risk.
  • If asked about anatomy teaching, reference standard fetal anomaly scan planes and placental localisation images (for example, see fetal anatomy and placental position figures in your core obstetric textbook).

Definition

Uncomplicated pregnancy is a singleton pregnancy in a woman without significant medical, obstetric, or social risk factors who is expected to need standard community-led antenatal care. In UK practice, this usually means routine midwife/GP-obstetric appointments (10 if nulliparous, 7 if parous) with standard screening and two routine ultrasound scans, while remaining alert for new complications that would trigger obstetric-led care.

Pathophysiology

Normal pregnancy involves maternal cardiovascular, renal, endocrine, haematological, and immunological adaptation to support placental function and fetal growth. Routine antenatal care does not treat a disease; it provides timed surveillance to detect deviation from normal physiology (for example hypertension, proteinuria, abnormal placentation, fetal growth problems, or gestational diabetes) early enough to reduce maternal and perinatal morbidity. The schedule of appointments and screening is designed around predictable physiological milestones in first, second, and third trimester development.

Risk Factors

  • Pre-existing maternal disease (for example chronic hypertension/cardiac disease, diabetes, renal/hepatic disease, autoimmune disease, epilepsy, severe asthma, haematological disorders, serious mental illness, HIV or hepatitis B)
  • BMI less than 18.5 kg/m2 or 30 kg/m2 and above at booking
  • Maternal age over 40 years at booking
  • Multiple pregnancy
  • Complex social factors (substance misuse, domestic abuse, language barriers, recent migration/asylum status, limited support, age under 20 years)
  • Previous pregnancy complications (for example pre-eclampsia, stillbirth, recurrent miscarriage, previous small- or large-for-gestational-age infant)
  • Complications arising in current pregnancy (for example placenta praevia, gestational hypertension, gestational diabetes, malpresentation, abnormal ultrasound findings)
  • Higher baseline adverse-outcome risk in some minority ethnic groups and in women living in deprivation (indicating need for closer support/monitoring)

Clinical Features

Symptoms

  • Often asymptomatic apart from expected pregnancy symptoms (nausea, fatigue, urinary frequency, reflux, back discomfort)
  • Progressive perception of fetal movements (typically from around 18-20 weeks, sometimes earlier in multiparous women)
  • No red-flag symptoms such as vaginal bleeding, persistent severe headache, visual disturbance, reduced fetal movements, severe abdominal pain, or fluid loss

Signs

  • Blood pressure within normal pregnancy range without sustained hypertension
  • Urinalysis negative for significant proteinuria (and no persistent glycosuria requiring escalation)
  • Symphysis-fundal height tracking gestation from 24 weeks onward
  • Fetal heart activity and lie/presentation appropriate for gestation
  • No oedema/signs suggestive of pre-eclampsia or other maternal pathology

Investigations

Booking blood tests (first trimester):FBC, blood group and Rh status, red-cell antibodies, and infection screening (HIV, hepatitis B, syphilis) within normal limits or managed promptly if abnormal
Urinalysis at appointments:No significant proteinuria or bacteriuria; abnormalities prompt urine culture and further assessment
Combined first-trimester ultrasound screening (11+2 to 14+1 weeks):Viable intrauterine singleton pregnancy, accurate dating, and screening risk estimate for aneuploidy communicated
Fetal anomaly scan (18+0 to 20+6 weeks):No major structural anomaly detected; placental site and fetal anatomy documented
Maternal blood pressure surveillance:No new gestational hypertension or pre-eclampsia indicators over serial checks
Assessment at each routine contact:Maternal wellbeing, mental health, safeguarding/domestic abuse enquiry, and fetal growth trajectory remain reassuring

Management

Lifestyle Modifications

  • Ensure booking appointment by 10+0 weeks where possible; if first contact is later than 9+0 weeks, arrange booking within 2 weeks
  • Follow routine UK appointment pathway (nulliparous: 10 contacts; parous: 7 contacts) plus additional visits if clinical or psychosocial needs arise
  • Provide ongoing advice on balanced diet, food safety (reduce food-borne infection risk), exercise, smoking cessation, alcohol avoidance, and avoidance of recreational drugs
  • Discuss emotional wellbeing, relationship changes, birth concerns, parenting support, and opportunities for partner involvement
  • Offer private one-to-one opportunities at appointments for disclosure of domestic abuse or mental health concerns
  • Review all prescribed, OTC, herbal, and supplement use; check pregnancy safety before continuing

Pharmacological Treatment

Periconception/antenatal supplementation

  • Folic acid 400 micrograms once daily from preconception until 12 weeks
  • Folic acid 5 mg once daily from preconception until 12 weeks for higher neural tube defect risk
  • Colecalciferol (vitamin D3) 10 micrograms (400 IU) once daily throughout pregnancy

Use 5 mg folic acid for women at increased risk (for example diabetes, anti-epileptic use, previous neural tube defect pregnancy, BMI 30 kg/m2 and above as locally guided). Avoid vitamin A (retinol) supplements in pregnancy because of teratogenic risk.

Smoking cessation support when needed

  • Nicotine replacement therapy (for example 15 mg/16 hour patch daily, with short-acting oral/inhaled NRT if required for breakthrough cravings)

NRT is generally safer than continued smoking in pregnancy; provide behavioural support alongside prescribing.

Complications

  • Late recognition of pre-eclampsia or gestational hypertension
  • Undetected fetal growth restriction or macrosomia
  • Missed gestational diabetes in women who newly develop risk indicators
  • Placental complications (for example placenta praevia) identified later than ideal
  • Maternal mental health deterioration if not actively screened
  • Safeguarding harm, including domestic abuse, if confidential enquiry is missed

Prognosis

With timely booking, routine surveillance, and rapid escalation when abnormalities emerge, maternal and fetal outcomes are generally very good in uncomplicated pregnancy. Prognosis worsens when risk factors are unrecognised, engagement is delayed, or evolving complications are not escalated to obstetric-led multidisciplinary care.

Sources & References

NICE Guidelines(1)

Test Your Knowledge

6 quiz questions available for this topic

Start Quiz